|
| 36790955 | Scaffolding Protein Connector Enhancer of Kinase Suppressor of Ras 1 (CNKSR1) Regulates MAPK Inhibition Responsiveness in Pancreas Cancer via Crosstalk with AKT Signaling. | Mol Cancer Res | 2023 |
| 37196527 | Determination of metarrestin (ML-246) in human plasma for a first-in-human clinical pharmacokinetic application by a simple and efficient uHPLC-MS/MS assay. | J Chromatogr B Analyt Technol Biomed Life Sci | 2023 |
| 37190294 | Regression and Eradication of Triple-Negative Breast Carcinoma in 4T1 Mouse Model by Combination Immunotherapies. | Cancers (Basel) | 2023 |
| 37174654 | A Novel CD206 Targeting Peptide Inhibits Bleomycin-Induced Pulmonary Fibrosis in Mice. | Cells | 2023 |
| 36790955 | Scaffolding Protein Connector Enhancer of Kinase Suppressor of Ras 1 (CNKSR1) Regulates MAPK Inhibition Responsiveness in Pancreas Cancer via Crosstalk with AKT Signaling. | Mol Cancer Res | 2023 |
| 37190294 | Regression and Eradication of Triple-Negative Breast Carcinoma in 4T1 Mouse Model by Combination Immunotherapies. | Cancers (Basel) | 2023 |
| 37174654 | A Novel CD206 Targeting Peptide Inhibits Bleomycin-Induced Pulmonary Fibrosis in Mice. | Cells | 2023 |
| 37196527 | Determination of metarrestin (ML-246) in human plasma for a first-in-human clinical pharmacokinetic application by a simple and efficient uHPLC-MS/MS assay. | J Chromatogr B Analyt Technol Biomed Life Sci | 2023 |
| 36250721 | Emerging kinase inhibitors for the treatment of pancreatic ductal adenocarcinoma. | Expert Opin Emerg Drugs | 2022 |
| 36250721 | Emerging kinase inhibitors for the treatment of pancreatic ductal adenocarcinoma. | Expert Opin Emerg Drugs | 2022 |
| 35754433 | Teaching principles of translational science to a broad scientific audience using a case study approach: A pilot course from the National Center for Advancing Translational Sciences. | J Clin Transl Sci | 2022 |
| 35696646 | Discovery and Optimization of Pyrrolopyrimidine Derivatives as Selective Disruptors of the Perinucleolar Compartment, a Marker of Tumor Progression toward Metastasis. | J Med Chem | 2022 |
| 35696646 | Discovery and Optimization of Pyrrolopyrimidine Derivatives as Selective Disruptors of the Perinucleolar Compartment, a Marker of Tumor Progression toward Metastasis. | J Med Chem | 2022 |
| 35754433 | Teaching principles of translational science to a broad scientific audience using a case study approach: A pilot course from the National Center for Advancing Translational Sciences. | J Clin Transl Sci | 2022 |
| 33405090 | Phase II study of selumetinib, an orally active inhibitor of MEK1 and MEK2 kinases, in KRAS<sup>G12R</sup>-mutant pancreatic ductal adenocarcinoma. | Invest New Drugs | 2021 |
| 34079928 | Mini-Review: PDPK1 (3-phosphoinositide dependent protein kinase-1), An Emerging Cancer Stem Cell Target. | J Cancer Treatment Diagn | 2021 |
| 33405090 | Phase II study of selumetinib, an orally active inhibitor of MEK1 and MEK2 kinases, in KRAS<sup>G12R</sup>-mutant pancreatic ductal adenocarcinoma. | Invest New Drugs | 2021 |
| 34376576 | T Cell-Mediated Antitumor Immunity Cooperatively Induced By TGFβR1 Antagonism and Gemcitabine Counteracts Reformation of the Stromal Barrier in Pancreatic Cancer. | Mol Cancer Ther | 2021 |
| 34376576 | T Cell-Mediated Antitumor Immunity Cooperatively Induced By TGFβR1 Antagonism and Gemcitabine Counteracts Reformation of the Stromal Barrier in Pancreatic Cancer. | Mol Cancer Ther | 2021 |
| 34079928 | Mini-Review: PDPK1 (3-phosphoinositide dependent protein kinase-1), An Emerging Cancer Stem Cell Target. | J Cancer Treatment Diagn | 2021 |
| 32185484 | Metabolism and pharmacokinetics characterization of metarrestin in multiple species. | Cancer Chemother Pharmacol | 2020 |
| 31649109 | Atypical KRAS<sup>G12R</sup> Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer. | Cancer Discov | 2020 |
| 32185484 | Metabolism and pharmacokinetics characterization of metarrestin in multiple species. | Cancer Chemother Pharmacol | 2020 |
| 32051227 | Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses. | Sci Transl Med | 2020 |
| 31931447 | LC-MS/MS assay coupled with carboxylic acid magnetic bead affinity capture to quantitatively measure cationic host defense peptides (HDPs) in complex matrices with application to preclinical pharmacokinetic studies. | J Pharm Biomed Anal | 2020 |
| 32766584 | A Novel CD206 Targeting Peptide Inhibits Bleomycin Induced Pulmonary Fibrosis in Mice. | bioRxiv | 2020 |
| 32619635 | Safety assessment of metarrestin in dogs: A clinical candidate targeting a subnuclear structure unique to metastatic cancer cells. | Regul Toxicol Pharmacol | 2020 |
| 31931447 | LC-MS/MS assay coupled with carboxylic acid magnetic bead affinity capture to quantitatively measure cationic host defense peptides (HDPs) in complex matrices with application to preclinical pharmacokinetic studies. | J Pharm Biomed Anal | 2020 |
| 32051227 | Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses. | Sci Transl Med | 2020 |
| 31649109 | Atypical KRAS<sup>G12R</sup> Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer. | Cancer Discov | 2020 |
| 32766584 | A Novel CD206 Targeting Peptide Inhibits Bleomycin Induced Pulmonary Fibrosis in Mice. | bioRxiv | 2020 |
| 32619635 | Safety assessment of metarrestin in dogs: A clinical candidate targeting a subnuclear structure unique to metastatic cancer cells. | Regul Toxicol Pharmacol | 2020 |
| 30745422 | Associations of CDH1 germline variant location and cancer phenotype in families with hereditary diffuse gastric cancer (HDGC). | J Med Genet | 2019 |
| 30745422 | Associations of CDH1 germline variant location and cancer phenotype in families with hereditary diffuse gastric cancer (HDGC). | J Med Genet | 2019 |
| 31395684 | Target Deconvolution of a Multikinase Inhibitor with Antimetastatic Properties Identifies TAOK3 as a Key Contributor to a Cancer Stem Cell-Like Phenotype. | Mol Cancer Ther | 2019 |
| 31395684 | Target Deconvolution of a Multikinase Inhibitor with Antimetastatic Properties Identifies TAOK3 as a Key Contributor to a Cancer Stem Cell-Like Phenotype. | Mol Cancer Ther | 2019 |
| 29214884 | Adjuvant intraperitoneal chemotherapy for the treatment of colorectal cancer at risk for peritoneal carcinomatosis: a systematic review. | Int J Hyperthermia | 2018 |
| 30306263 | Pharmacokinetic evaluation of the PNC disassembler metarrestin in wild-type and Pdx1-Cre;LSL-Kras[G12D/+];Tp53[R172H/+] (KPC) mice, a genetically engineered model of pancreatic cancer. | Cancer Chemother Pharmacol | 2018 |
| 30064387 | Loss of PDPK1 abrogates resistance to gemcitabine in label-retaining pancreatic cancer cells. | BMC Cancer | 2018 |
| 30584346 | Gastric adenocarcinoma and proximal polyposis of the stomach: diagnosis and clinical perspectives. | Clin Exp Gastroenterol | 2018 |
| 29214884 | Adjuvant intraperitoneal chemotherapy for the treatment of colorectal cancer at risk for peritoneal carcinomatosis: a systematic review. | Int J Hyperthermia | 2018 |
| 29468433 | Merging perspectives: genotype-directed molecular therapy for hereditary diffuse gastric cancer (HDGC) and E-cadherin-EGFR crosstalk. | Clin Transl Med | 2018 |
| 29769289 | Metarrestin, a perinucleolar compartment inhibitor, effectively suppresses metastasis. | Sci Transl Med | 2018 |
| 29145578 | The Changing Paradigm of Management of Liver Abscesses in Chronic Granulomatous Disease. | Clin Infect Dis | 2018 |
| 30064387 | Loss of PDPK1 abrogates resistance to gemcitabine in label-retaining pancreatic cancer cells. | BMC Cancer | 2018 |
| 30306263 | Pharmacokinetic evaluation of the PNC disassembler metarrestin in wild-type and Pdx1-Cre;LSL-Kras[G12D/+];Tp53[R172H/+] (KPC) mice, a genetically engineered model of pancreatic cancer. | Cancer Chemother Pharmacol | 2018 |
| 30584346 | Gastric adenocarcinoma and proximal polyposis of the stomach: diagnosis and clinical perspectives. | Clin Exp Gastroenterol | 2018 |
| 29468433 | Merging perspectives: genotype-directed molecular therapy for hereditary diffuse gastric cancer (HDGC) and E-cadherin-EGFR crosstalk. | Clin Transl Med | 2018 |
| 29769289 | Metarrestin, a perinucleolar compartment inhibitor, effectively suppresses metastasis. | Sci Transl Med | 2018 |
| 29145578 | The Changing Paradigm of Management of Liver Abscesses in Chronic Granulomatous Disease. | Clin Infect Dis | 2018 |